Related Experiment Video
Updated: Oct 6, 2025

07:38
Strategies for Assessing Autistic-Like Behaviors in Mice
Published on: September 20, 2024
1.4K
Abnormal mTOR Activity in Pediatric Autoimmune Neuropsychiatric and MIA-Associated Autism Spectrum Disorders
Ekaterina A Trifonova1, Zakhar S Mustafin1,2, Sergey A Lashin1,2
1Federal Research Center Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia.
International Journal of Molecular Sciences
|January 21, 2022
Summary
This review links mammalian target of rapamycin (mTOR) signaling to maternal autoantibody-related (MAR) autism spectrum disorder (ASD). It highlights the need for subtyping ASD based on pathogenic mechanisms and developing antibody tests.
Area of Science:
- Neuroscience
- Genetics
- Immunology
Background:
- Autism spectrum disorder (ASD) is a neurodevelopmental condition with early onset of communication and behavioral issues.
- While highly heritable, environmental factors significantly influence ASD development.
- Dysregulation of mammalian target of rapamycin (mTOR)-dependent translation is implicated in a substantial portion of autism cases.
Purpose of the Study:
- To review evidence connecting mTOR signaling with maternal autoantibody-related (MAR) autism spectrum and autoimmune neuropsychiatric disorders.
- To reconstruct the interaction network between mTOR signaling and eight MAR ASD genes.
- To explore the necessity of developing diagnostic tools for antibody-related autism.
Main Methods:
- Narrative review of bioinformatic and experimental evidence.
- Network reconstruction of gene interactions.
- Analysis of existing research on mTOR signaling and MAR ASD.
Main Results:
- Evidence links mTOR signaling to MAR autism spectrum disorders.
- A network illustrating interactions between mTOR signaling and MAR ASD genes was constructed.
- The study underscores the need for ASD subtyping based on pathogenic mechanisms.
Conclusions:
- mTOR signaling is a key factor in MAR autism spectrum disorders.
- Subtyping ASD by pathogenic mechanisms is crucial for targeted interventions.
- Development of ELISA-based tests for autism-related antibodies is recommended.
Related Concept Videos
Autism Spectrum Disorder
464
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
464
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway
4.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.1K

